Purified anti-SARS-CoV-2 Nucleocapsid Antibody, SARS-CoV-2, A20087H,BioLegend,946101

SARS-CoV-2 is 90% homologous to SARS-CoV. Cross reactivity of anti-SARS-CoV-2 Nucleocapsid antibody (clone A20087H) with SARS-CoV has not been tested.BioLegend offers two clones specific for SARS-CoV-2 nucleocapsid, clones A20087F and A20087HBoth clones have been verified for western blot, with A20087F showing a higher affinity for SARS-CoV-2 nucleocapsid for this applicationBoth clones have been verified for direct ELISA and displayed similar EC50values for this applicationA20087H has been verified for ICFC, while A20087F is not recommended for this application

Host

Mouse

Reactivity

SARS-CoV-2

Application

WB - Quality testedDirect ELISA, ICFC - Verified

Platform ID

BAB990160341

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-SARS-CoV-2 Nucleocapsid Antibody, SARS-CoV-2, A20087H
Cat. No.946101
HostMouse
RRIDAB_2892515 (BioLegend Cat. No. 946101)AB_2892515 (BioLegend Cat. No. 946102)
IsotypeMouse IgG2b, κ
ReactivitySARS-CoV-2
ApplicationWB - Quality testedDirect ELISA, ICFC - Verified
ClonalityMonoclonal
Clone NumberA20087H
Concentration0.5 mg/mL
TargetViral Protein
ImmunogenSARS-CoV-2 Nucleocapsid recombinant protein
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a single stranded RNA virus that belongs in a family of viruses known as coronaviruses.   SARS-CoV-2 infection, known as COVID-19, was declared a pandemic in 2020 and among other symptoms leads to respiratory infection, pulmonary failure which can be fatal. SARS-CoV-2 is structurally composed of 4 main proteins (e.g. spike glycoprotein, envelope glycoprotein, membrane glycoprotein and nucleocapsid protein) and several accessory proteins.The SARS-CoV-2 Nucleocapsid (N) is an abundant protein, that binds to the viral RNA and helps stabilize it. It has been proposed that N protein forms bimolecular condensates that both regulate viral replication and modulate the host response to the virus following infection.  N protein is a major antigen that the host immune response is directed to following SARS CoV-2 infection making it a promising candidate for vaccine development and drug therapy.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.